Xtrackers MSCI World Ex Usa UCITS ETF (LON:EXUS)
London · Delayed Price · Currency is GBP · Price in USD 43.78
+0.84 (1.96%)
Apr 30, 2026, 4:35 PM GMT
26.65% (1Y)
| Assets | 4.52B |
| Expense Ratio | 15.00% |
| PE Ratio | 17.95 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +26.65% |
| Volume | 77,973 |
| Open | 42.76 |
| Previous Close | 42.94 |
| Day's Range | 42.76 - 43.78 |
| 52-Week Low | 34.21 |
| 52-Week High | 49.48 |
| Beta | 0.87 |
| Holdings | 788 |
| Inception Date | Mar 6, 2024 |
About EXUS
The MSCI World ex USA Index aims to reflect the performance of the following market: Large and mid-cap companies from global developed markets excluding the United States of America Covers approximately 85% of free-float market capitalisation Weighted by free-float adjusted market capitalisation Reviewed on a quarterly basis Additional information on the index, selection and weighting methodology is available at https://www.msci.com
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol EXUS
Provider Xtrackers
Index Tracked MSCI World ex USA
Performance
EXUS had a total return of 26.65% in the past year, including dividends. Since the fund's inception, the average annual return has been 17.83%.
Top 10 Holdings
14.66% of assets| Name | Symbol | Weight |
|---|---|---|
| Bought Usd/Sold Jpy | n/a | 3.46% |
| ASML Holding N.V. | ASML | 2.18% |
| AstraZeneca PLC | AZN | 1.31% |
| Novartis AG | NOVN | 1.24% |
| HSBC Holdings plc | HSBA | 1.20% |
| Roche Holding AG | ROP | 1.20% |
| Shell plc | SHEL | 1.17% |
| Nestlé S.A. | NESN | 1.09% |
| Royal Bank of Canada | RY | 0.98% |
| Commonwealth Bank of Australia | CBA | 0.84% |